Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)
Oertel K, Spiegel K, Schmalenberg H, Dietz A, Maschmeyer G, Kuhnt T, Sudhoff H, Wendt TG, Guntinas-Lichius O (2012)
BMC Cancer 12(1): 483.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Oertel, Katrin;
Spiegel, Karin;
Schmalenberg, Harald;
Dietz, Andreas;
Maschmeyer, Georg;
Kuhnt, Thomas;
Sudhoff, HolgerUniBi 
;
Wendt, Thomas G;
Guntinas-Lichius, Orlando
;
Wendt, Thomas G;
Guntinas-Lichius, OrlandoErscheinungsjahr
2012
Zeitschriftentitel
BMC Cancer
Band
12
Ausgabe
1
Art.-Nr.
483
eISSN
1471-2407
Page URI
https://pub.uni-bielefeld.de/record/2951885
Zitieren
Oertel K, Spiegel K, Schmalenberg H, et al. Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). BMC Cancer. 2012;12(1): 483.
Oertel, K., Spiegel, K., Schmalenberg, H., Dietz, A., Maschmeyer, G., Kuhnt, T., Sudhoff, H., et al. (2012). Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). BMC Cancer, 12(1), 483. https://doi.org/10.1186/1471-2407-12-483
Oertel, Katrin, Spiegel, Karin, Schmalenberg, Harald, Dietz, Andreas, Maschmeyer, Georg, Kuhnt, Thomas, Sudhoff, Holger, Wendt, Thomas G, and Guntinas-Lichius, Orlando. 2012. “Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)”. BMC Cancer 12 (1): 483.
Oertel, K., Spiegel, K., Schmalenberg, H., Dietz, A., Maschmeyer, G., Kuhnt, T., Sudhoff, H., Wendt, T. G., and Guntinas-Lichius, O. (2012). Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). BMC Cancer 12:483.
Oertel, K., et al., 2012. Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). BMC Cancer, 12(1): 483.
K. Oertel, et al., “Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)”, BMC Cancer, vol. 12, 2012, : 483.
Oertel, K., Spiegel, K., Schmalenberg, H., Dietz, A., Maschmeyer, G., Kuhnt, T., Sudhoff, H., Wendt, T.G., Guntinas-Lichius, O.: Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1). BMC Cancer. 12, : 483 (2012).
Oertel, Katrin, Spiegel, Karin, Schmalenberg, Harald, Dietz, Andreas, Maschmeyer, Georg, Kuhnt, Thomas, Sudhoff, Holger, Wendt, Thomas G, and Guntinas-Lichius, Orlando. “Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)”. BMC Cancer 12.1 (2012): 483.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 23083061
PubMed | Europe PMC
Suchen in
Google Scholar